Zoono Group Limited (ZNO.AX)
AUD 0.02
(-8.0%)
AUD 0.02
(-8.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.16 Million | -3.86 Million | -1.07 Million | 1.47 Million | 8.17 Million | -2.82 Million |
| Net Income | -9.08 Million | -348.32 Thousand | -11.79 Million | 4.71 Million | 16.82 Million | -2.37 Million |
| Depreciation & Amortization | 232.14 Thousand | 253.85 Thousand | 320.79 Thousand | 358.83 Thousand | 199.42 Thousand | 88.24 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 452.88 Thousand | 545.54 Thousand | 703.61 Thousand | 279.63 Thousand | 942.01 Thousand | 39.52 Thousand |
| Change in working capital | 5.62 Million | 978.56 Thousand | 3.93 Million | -4.92 Million | -9.89 Million | -582.28 Thousand |
| Other non-cash items | -383.97 Thousand | -4.74 Million | 6.45 Million | 1.32 Million | 1.04 Million | 40.57 Thousand |
| Investing Cash Flow | -58.72 Thousand | -58.16 Thousand | -123.47 Thousand | -1.34 Million | -138.78 Thousand | -33.68 Thousand |
| Investments in PPE | - | - | -24.86 Thousand | -584.33 Thousand | -138.78 Thousand | -33.68 Thousand |
| Acquisitions | -59.37 Thousand | -58.16 Thousand | -98.6 Thousand | -763.29 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 703.00 | - | -1.10 | -1.00 | - | - |
| Financing Cash Flow | 3.98 Million | 945.12 Thousand | -63.09 Thousand | -5.17 Million | -197.95 Thousand | -26.96 Thousand |
| Debt repayment | -138.23 Thousand | -165.91 Thousand | -271.03 Thousand | -257.81 Thousand | -194.96 Thousand | -25.11 Thousand |
| Dividends payments | - | - | - | -4.74 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | -1882.92 |
| Common Stock Issuance | 4.12 Million | 1.11 Million | 218.59 Thousand | 166.15 Thousand | - | -1846.95 |
| Other Financing Activities | 4.5 Million | 694.30 | -10.65 Thousand | -5.50 | - | 1882.29 |
| Accounts receivables | 62.98 Thousand | 563.15 Thousand | 4.44 Million | 3.26 Million | -8.49 Million | -572.25 Thousand |
| Accounts payables | - | -822.8 Thousand | -316.25 Thousand | -6.18 Million | 7.74 Million | -194.83 Thousand |
| Inventory | 5.49 Million | 1.17 Million | -6860.39 | 982.85 Thousand | -12.82 Million | 165.06 Thousand |
| Other working capital | 68.21 Thousand | 66.94 Thousand | -184.03 Thousand | -2.98 Million | 3.67 Million | 19.74 Thousand |
| Cash at beginning of period | 756.37 Thousand | 3.19 Million | 4.66 Million | 3.79 Million | 131.4 Thousand | 5.84 Million |
| Cash at end of period | 1.79 Million | 826.4 Thousand | 3.24 Million | 4.53 Million | 3.77 Million | 129.03 Thousand |
| Capital Expenditure | - | - | -24.86 Thousand | -584.33 Thousand | -138.78 Thousand | -33.68 Thousand |
| Effect of forex changes on cash | 5792.07 | 159.78 Thousand | -19.74 Thousand | -367.01 Thousand | -557.05 Thousand | -27.55 Thousand |
| Net cash flow / Change in cash | 1.03 Million | -2.36 Million | -1.42 Million | 735.9 Thousand | 3.64 Million | -5.71 Million |
| Free Cash Flow | -3.16 Million | -3.86 Million | -1.1 Million | 895 Thousand | 8.03 Million | -2.85 Million |
| Breakdown | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.15 Million | -5.93 Million | -348.32 Thousand | -1.71 Million | 1.36 Million | -11.79 Million |
| Depreciation & Amortization | 114.49 Thousand | 117.65 Thousand | 253.85 Thousand | 112.73 Thousand | 140.05 Thousand | 320.79 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 125.76 Thousand | 327.11 Thousand | 545.54 Thousand | 292.07 Thousand | 299.91 Thousand | 703.61 Thousand |
| Change in working capital | 5.62 Million | - | 978.56 Thousand | 1.9 Million | - | 3.93 Million |
| Other non-cash items | -4.27 Million | 3.88 Million | -4.74 Million | -1.39 Million | -4.89 Million | 6.45 Million |
| Investing Cash Flow | -28.34 Thousand | -35.83 Thousand | -58.16 Thousand | -58.51 Thousand | - | -123.47 Thousand |
| Investments in PPE | - | - | - | - | - | -24.86 Thousand |
| Acquisitions | -64.87 Thousand | - | -58.16 Thousand | -58.51 Thousand | - | -98.6 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 36.53 Thousand | -35.83 Thousand | - | - | - | -1.10 |
| Financing Cash Flow | 3.41 Million | 937.7 Thousand | 945.12 Thousand | 1.04 Million | -90.95 Thousand | -63.09 Thousand |
| Debt repayment | - | -75.04 Thousand | -165.91 Thousand | - | -90.95 Thousand | -271.03 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 481.12 Thousand | 1.11 Million | 1.12 Million | - | 218.59 Thousand |
| Other Financing Activities | 3.41 Million | 1.01 Million | 694.30 | 1.04 Million | - | -10.65 Thousand |
| Accounts receivables | 62.98 Thousand | - | 563.15 Thousand | 566.5 Thousand | - | 4.44 Million |
| Accounts payables | - | - | -822.8 Thousand | - | - | -316.25 Thousand |
| Inventory | 5.49 Million | - | 1.17 Million | 1.17 Million | - | -6860.39 |
| Other working capital | 68.21 Thousand | - | 66.94 Thousand | 162.15 Thousand | - | -184.03 Thousand |
| Cash at beginning of period | 136.31 Thousand | 819.23 Thousand | 3.19 Million | 457.3 Thousand | 3.13 Million | 4.66 Million |
| Cash at end of period | 1.96 Million | 136.31 Thousand | 826.4 Thousand | 826.4 Thousand | 457.3 Thousand | 3.24 Million |
| Capital Expenditure | - | - | - | - | - | -24.86 Thousand |
| Effect of forex changes on cash | -419.00 | 6748.00 | 159.78 Thousand | 189.83 Thousand | -29.77 Thousand | -19.74 Thousand |
| Net cash flow / Change in cash | 1.82 Million | -682.92 Thousand | -2.36 Million | 369.1 Thousand | -2.67 Million | -1.42 Million |
| Free Cash Flow | -1.56 Million | -1.59 Million | -3.86 Million | -803.84 Thousand | -3.08 Million | -1.1 Million |
AXOLOT
GCI
002132
601998
200625
AMA